2.Laparoscopic resection of a huge gangrenous Meckel's diverticulum in an adult.
Marc Weijie ONG ; Ker Kan TAN ; Richard SIM
Singapore medical journal 2013;54(4):e83-4
This report highlights the rare occurrence of a huge gangrenous Meckel's diverticulum in an adult, which was managed successfully with laparoscopic resection. A 45-year-old woman presented with a one-day history of right iliac fossa pain with fever and vomiting. Computed tomography showed a huge gangrenous Meckel's diverticulum. The patient underwent laparoscopic exploration and extracorporeal stapled resection of the Meckel's diverticulum. This case serves to highlight the safety and feasibility of performing a laparoscopic resection of a huge gangrenous Meckel's diverticulum in an adult.
Female
;
Gangrene
;
diagnostic imaging
;
surgery
;
Humans
;
Laparoscopy
;
Meckel Diverticulum
;
diagnostic imaging
;
surgery
;
Middle Aged
;
Tomography, X-Ray Computed
;
Treatment Outcome
3.Physician-prescribed Asthma Treatment Regimen does not differ Between Smoking and Non-smoking Patients With Asthma in Seoul and Gyunggi province of Korea.
Hae Sim PARK ; Ki Suck JUNG ; Kian Fan CHUNG ; Felicia ALLEN-RAMEY ; Ryan POLLARD ; Richard PERRY ; David PRICE
Allergy, Asthma & Immunology Research 2015;7(1):30-36
PURPOSE: Smoking has detrimental effects on asthma symptom control and response to treatment and is prevalent among asthma patients in South Korea. The aim of this study is to determine the prevalence of smoking among asthma patients in South Korea and to compare the medication regimens of asthma patients who do and do not smoke. METHODS: A cross-sectional survey was conducted from August 2010 to January 2011. Participating physicians (N=25) recorded demographic and clinical data on all asthma patients presenting during the study period (N=2,032), and then recruited a subset of patients (N=500) for the survey such that half were self-reported current smokers. Recruited patients were between the ages of 18 and 60. RESULTS: Among presenting asthma patients, 17.3% were current smokers, 19.2% were former smokers, and 63.5% had never smoked. Within the analyzable study population (N=471), 212 patients reported smoking currently, 79 smoking formerly, and 180 never smoking. Among current and former smokers, 79.7% and 81.0%, respectively, were men, while women represented 80.5% of patients who had never smoked. Agreement was strong between physician-determined smoking status and patient-reported smoking status (kappa=0.82; P<0.001). However, asthma medication regimens examined according to GINA treatment steps did not differ by smoking status. In addition, mean quality of life scores and level of asthma control did not differ by smoking status. CONCLUSIONS: In South Korea, physicians are well aware of the smoking status of their patients. However, smoking status did not affect the prescribed medication regimens of this population of asthma patients.
Asthma*
;
Cross-Sectional Studies
;
Female
;
Humans
;
Korea
;
Male
;
Prevalence
;
Quality of Life
;
Seoul
;
Smoke*
;
Smoking*
4.Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function.
Mark Y CHAN ; Richard C BECKER ; Ling-Ling SIM ; Virlynn TAN ; Chi-Hang LEE ; Adrian F H LOW ; Swee-Guan TEO ; Kheng-Siang NG ; Huay-Cheem TAN ; Tiong-Cheng YEO
Annals of the Academy of Medicine, Singapore 2010;39(3):179-184
INTRODUCTIONSeveral randomised controlled trials have demonstrated better outcomes with primary percutaneous coronary intervention (PCI) over fibrinolytic therapy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI) and normal renal function. Whether this benefit extends to patients with impaired renal function is uncertain.
MATERIALS AND METHODSWe studied 1672 patients with STEMI within 12 hours of symptom onset who were admitted to 2 major public hospitals in Singapore from 2000 to 2002. All patients received either upfront fibrinolytic or PCI as determined by the attending cardiologist. Serum creatinine was measured on admission and the glomerular filtration rate (GFR) was determined using the Modification of Diet in Renal Disease equation. The impact of reperfusion strategy on 30-ay mortality was then determined for patients with GFR > or =60 mL min-(1) 1.73 m-(2) and GFR <60 mL min-(1) 1.73 m-(2).
RESULTSThe mean age was 56 +/- 12 years (85% male) and mean GFR was 81 +/- 30 mL min-(1) 1.73 m-(2). Unadjusted 30-day mortality rates for fibrinolytic-treated vs primary PCI-treated patients were 29.4% vs 17.9%, P <0.05, in the impaired renal function group and 5.4% vs 3.1%, P <0.05, in the normal renal function group. After adjusting for covariates, primary PCI was associated with a significantly lower mortality in the normal renal function group [odds ratio (OR), 0.41; 95% confidence interval (CI), 0.19-0.89] but not in the impaired renal function group [OR, 0.70; 95% CI, 0.31-1.60].
CONCLUSIONSPrimary PCI was associated with improved 30-day survival among patients with normal renal function but not among those with impaired renal function. Randomised trials are needed to study the relative efficacy of both reperfusion strategies in patients with impaired renal function.
Adult ; Angioplasty, Balloon, Coronary ; Antifibrinolytic Agents ; therapeutic use ; Electrocardiography ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Myocardial Infarction ; complications ; drug therapy ; surgery ; Registries ; Renal Insufficiency, Chronic ; complications ; Retrospective Studies ; Survival Analysis
5.Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
Yiat Horng LEONG ; Cheng Nang LEONG ; Guan Sze TAY ; Richard SIM ; Gilberto LOPES ; Wilson LOW ; Bok Ai CHOO ; Jeremy TEY
Annals of the Academy of Medicine, Singapore 2014;43(12):569-575
INTRODUCTIONThis study reports the outcomes of patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation followed by surgery in a local population of Singapore.
MATERIALS AND METHODSThe records of 85 patients who underwent neoadjuvant chemoradiation for locally advanced rectal cancer followed by surgery at the Tan Tock Seng Hospital (TTSH) between November 2002 and January 2012 were reviewed. The treatment protocol comprised radiotherapy to a total dose of 50.4 Gy concurrent with 5-fluorouracil-based chemotherapy. Patients underwent total mesorectal excision surgery following the completion of neoadjuvant chemoradiation. Local control, disease-free survival and overall survival were analysed using Kaplan-Meier methods.
RESULTSMedian age of the patients was 61 years. All of them completed radiotherapy. One patient did not complete neoadjuvant chemotherapy. The median time to surgery was 52 days. Fifty-five percent (47 of 85) of patients achieved pathological downstaging and 13% (11 of 85) of patients had a pathologic complete response to preoperative treatment. The neoadjuvant chemoradiation was well tolerated. Four percent of patients had grade 3 diarrhoea and 4% of them had grade 3 dermatitis. There were no grade 4 toxicities. With a median follow-up of 41 months, the 5-year actuarial local recurrence, disease-free survival and overall survival rates were 7%, 71.9%, and 83.2% respectively. Univariate analysis showed that patients with positive surgical margins had significantly worse disease-free survival and overall survival (P=0.012 and P<0.001 respectively) and a trend towards a higher rate of local recurrence (P=0.08).
CONCLUSIONOur study provides evidence that neoadjuvant chemoradiation is an effective treatment for locally advanced rectal cancer. Our outcomes are comparable with internationally published data and demonstrate the reproducibility of the neoadjuvant approach in an Asian population.
Adult ; Aged ; Aged, 80 and over ; Chemoradiotherapy, Adjuvant ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Rectal Neoplasms ; pathology ; therapy ; Treatment Outcome
6.Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
Kristelle S BROWN ; Michael J KEOGH ; Ania M OWSIANKA ; Richard ADAIR ; Arvind H PATEL ; James N ARNOLD ; Jonathan K BALL ; Robert B SIM ; Alexander W TARR ; Timothy P HICKLING
Protein & Cell 2010;1(7):664-674
Mannan-binding lectin (MBL) is a soluble innate immune protein that binds to glycosylated targets. MBL acts as an opsonin and activates complement, contributing to the destruction and clearance of infecting microorganisms. Hepatitis C virus (HCV) encodes two envelope glycoproteins E1 and E2, expressed as non-covalent E1/E2 heterodimers in the viral envelope. E1 and E2 are potential ligands for MBL. Here we describe an analysis of the interaction between HCV and MBL using recombinant soluble E2 ectodomain fragment, the full-length E1/E2 heterodimer, expressed in vitro, and assess the effect of this interaction on virus entry. A binding assay using antibody capture of full length E1/E2 heterodimers was used to demonstrate calcium dependent, saturating binding of MBL to HCV glycoproteins. Competition with various saccharides further confirmed that the interaction was via the lectin domain of MBL. MBL binds to E1/E2 representing a broad range of virus genotypes. MBL was shown to neutralize the entry into Huh-7 cells of HCV pseudoparticles (HCVpp) bearing E1/E2 from a wide range of genotypes. HCVpp were neutralized to varying degrees. MBL was also shown to neutralize an authentic cell culture infectious virus, strain JFH-1 (HCVcc). Furthermore, binding of MBL to E1/E2 was able to activate the complement system via MBL-associated serine protease 2. In conclusion, MBL interacts directly with HCV glycoproteins, which are present on the surface of the virion, resulting in neutralization of HCV particles.
Binding, Competitive
;
Glycosylation
;
Hepacivirus
;
genetics
;
pathogenicity
;
physiology
;
Humans
;
Mannose-Binding Lectin
;
metabolism
;
Mannose-Binding Protein-Associated Serine Proteases
;
metabolism
;
Monosaccharides
;
metabolism
;
Protein Binding
;
Protein Multimerization
;
Tumor Cells, Cultured
;
Viral Envelope Proteins
;
metabolism
;
Virion
;
pathogenicity
;
physiology
;
Virus Internalization
7.Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
Isaac M WESTWOOD ; Sanjib BHAKTA ; Angela J RUSSELL ; Elizabeth FULLAM ; Matthew C ANDERTON ; Akane KAWAMURA ; Andrew W MULVANEY ; Richard J VICKERS ; Veemal BHOWRUTH ; Gurdyal S BESRA ; Ajit LALVANI ; Stephen G DAVIES ; Edith SIM
Protein & Cell 2010;1(1):82-95
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for treatment and also to identify agents that will be effective against Mycobacterium tuberculosis persisting intracellularly. Mycobacteria have a unique cell wall. Deletion of the gene for arylamine N-acetyltransferase (NAT) decreases mycobacterial cell wall lipids, particularly the distinctive mycolates, and also increases antibiotic susceptibility and killing within macrophage of Mycobacterium bovis BCG. The nat gene and its associated gene cluster are almost identical in sequence in M. bovis BCG and M. tuberculosis. The gene cluster is essential for intracellular survival of mycobacteria. We have therefore used pure NAT protein for high-throughput screening to identify several classes of small molecules that inhibit NAT activity. Here, we characterize one class of such molecules-triazoles-in relation to its effects on the target enzyme and on both M. bovis BCG and M. tuberculosis. The most potent triazole mimics the effects of deletion of the nat gene on growth, lipid disruption and intracellular survival. We also present the structure-activity relationship between NAT inhibition and effects on mycobacterial growth, and use ligand-protein analysis to give further insight into the structure-activity relationships. We conclude that screening a chemical library with NAT protein yields compounds that have high potential as anti-tubercular agents and that the inhibitors will allow further exploration of the biochemical pathway in which NAT is involved.
Antitubercular Agents
;
chemistry
;
isolation & purification
;
pharmacology
;
Arylamine N-Acetyltransferase
;
antagonists & inhibitors
;
chemistry
;
Enzyme Inhibitors
;
chemistry
;
isolation & purification
;
pharmacology
;
High-Throughput Screening Assays
;
Humans
;
Mycobacterium bovis
;
drug effects
;
enzymology
;
genetics
;
Mycobacterium tuberculosis
;
drug effects
;
enzymology
;
genetics
;
Protein Conformation
;
Structure-Activity Relationship
;
Triazoles
;
chemistry
;
isolation & purification
;
pharmacology